Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Amicus Therapeutics (FOLD) Other Gross PP&E Adjustments (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Other Gross PP&E Adjustments for 14 consecutive years, with $37.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 5.33% year-over-year to $37.8 million, compared with a TTM value of $37.8 million through Dec 2025, up 5.33%, and an annual FY2025 reading of $37.8 million, up 5.33% over the prior year.
  • Other Gross PP&E Adjustments was $37.8 million for Q4 2025 at Amicus Therapeutics, up from -$21.5 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $41.8 million in Q4 2021 and bottomed at -$32.0 million in Q3 2023.
  • Average Other Gross PP&E Adjustments over 5 years is -$10.6 million, with a median of -$22.3 million recorded in 2021.
  • The sharpest move saw Other Gross PP&E Adjustments soared 31.19% in 2021, then crashed 43.71% in 2022.
  • Year by year, Other Gross PP&E Adjustments stood at $41.8 million in 2021, then tumbled by 43.71% to $23.5 million in 2022, then surged by 30.86% to $30.8 million in 2023, then grew by 16.55% to $35.9 million in 2024, then rose by 5.33% to $37.8 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for FOLD at $37.8 million in Q4 2025, -$21.5 million in Q3 2025, and -$22.0 million in Q2 2025.